Position in INSM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,358,007
-$12,705 QoQ
Shares Held
22,116
+52.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#274
of 663 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $597,315,774 across 9 Biotechnology names. INSM ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
4,319,595 | $242,199,691 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,810,815 | $141,732,490 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
241,280 | $119,851,014 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
213,589 | $64,296,696 | |
| 5 | INCY |
Incyte Corp
|
190,323 | $21,575,015 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,887 | $2,423,699 | |
| 7 | INSM |
INSMED Inc
This page
|
22,116 | $2,358,007 | |
| 8 | LEGN |
Legend Biotech Corp
|
75,000 | $2,166,000 |
All Filings in INSM
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,358,007 | 22,116 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,370,712 | 14,498 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,481,080 | 8,510 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||